Investigational Drug Information for Psilocybin
✉ Email this page to a colleague
What is the development status for investigational drug Psilocybin?
Psilocybin is an investigational drug.
There have been 132 clinical trials for Psilocybin.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2022.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Disease. The leading clinical trial sponsors are Johns Hopkins University, COMPASS Pathways, and Heffter Research Institute.
There are seven hundred and twenty-six US patents protecting this investigational drug and two international patents.
Summary for Psilocybin
| US Patents | 726 |
| International Patents | 2,399 |
| US Patent Applications | 2,063 |
| WIPO Patent Applications | 674 |
| Japanese Patent Applications | 25 |
| Clinical Trial Progress | Phase 2 (2022-11-01) |
| Vendors | 18 |
Recent Clinical Trials for Psilocybin
| Title | Sponsor | Phase |
|---|---|---|
| Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer | Steven and Alexandra Cohen Foundation | Phase 1/Phase 2 |
| Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer | University of Washington | Phase 1/Phase 2 |
| Pairing Psilocybin With Transauricular Vagus Nerve Stimulation | Tiny Blue Dot Foundation | Phase 1 |
Clinical Trial Summary for Psilocybin
Top disease conditions for Psilocybin
Top clinical trial sponsors for Psilocybin
US Patents for Psilocybin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Psilocybin | ⤷ Try a Trial | Devices and methods for continuous analyte monitoring | DexCom, Inc. (San Diego, CA) | ⤷ Try a Trial |
| Psilocybin | ⤷ Try a Trial | Devices and methods for continuous analyte monitoring | DexCom, Inc. (San Diego, CA) | ⤷ Try a Trial |
| Psilocybin | ⤷ Try a Trial | Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods | DexCom, Inc. (San Diego, CA) | ⤷ Try a Trial |
| Psilocybin | ⤷ Try a Trial | Advanced analyte sensor calibration and error detection | DexCom, Inc. (San Diego, CA) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Psilocybin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Psilocybin | Denmark | DK3069279 | 2033-11-14 | ⤷ Try a Trial |
| Psilocybin | European Patent Office | EP3069279 | 2033-11-14 | ⤷ Try a Trial |
| Psilocybin | European Patent Office | EP3796332 | 2033-11-14 | ⤷ Try a Trial |
| Psilocybin | World Intellectual Property Organization (WIPO) | WO2015073459 | 2033-11-14 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
